Llwytho...
Evaluation of the COVID19 ID NOW EUA assay
BACKGROUND: The SARS-CoV-2 pandemic caused a major surge in needed diagnostic capacity. In response, many EUA assays have become available for clinical laboratories, and more recently, the point of care device, Abbott ID NOW. OBJECTIVES: To determine the analytical performance of the ID NOW assay fo...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Clin Virol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier B.V.
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227587/ https://ncbi.nlm.nih.gov/pubmed/32425657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2020.104429 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|